Zobrazeno 1 - 10 of 64 pro vyhledávání: '"Nicolo' Gebbia"'
2
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers
Autor: Fabio Fulfaro, D. Santangelo, Giuseppe Badalamenti, R. Di Leo, Francesco Verderame, Gaspare Gulotta, Maria Rosaria Valerio, Giuseppe Cicero, Giovanni Tomasello, Nicolo' Gebbia, Antonio Russo
Publikováno v: Annals of Oncology. 17:vii68-vii72
Background Biliary tract cancers are uncommon tumors with a poor prognosis and most patients present with invasive and inoperable disease at diagnosis. Chemotherapy represents a palliative treatment, with poor response rates and a median survival of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d113ae37874e2d9a887f0eda5846632e
https://doi.org/10.1093/annonc/mdl955
Zobrazit plný text záznamu
4
FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale (GOIM)
Autor: Nicolo' Gebbia, Francesco Giuliani, L. Manzione, Giuseppe Colucci, G. Pezzella, Evaristo Maiello, Nicola Borsellino, M. Lopez, Vittorio Gebbia, Giacomo Cartenì, G. Paoletti, S. Romito
Publikováno v: Annals of Oncology. 16:iv56-iv60
Purpose: To verify the experience of the GOIM in the treatment of advanced colorectal cancer patients with the FOLFIRI combination therapy. Patients and methods: Patients entered in three consecutive trials of the GOIM (protocols no. 9706, 9901, and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6da45b898a3ca75a8920351f30af7fd8
https://doi.org/10.1093/annonc/mdi909
Zobrazit plný text záznamu
5
Escalating doses of paclitaxel and epirubicin in combination with cisplatin in advanced ovarian epithelial carcinoma: a phase I–II study
Autor: Nicolo' Gebbia, Citarrella P, Nicolò Borsellino, Roberto Valenza, Pietro Di Marco, Giuseppina Fallica, Maria Rosaria Valerio, Maria Lina Tirrito, Pierluigi Benedetti Panici, Vittorio Gebbia
Publikováno v: Anti-Cancer Drugs. 14:359-364
Our objective was to identify a new active three-drug combination regimen consisting of paclitaxel (PTX), epirubicin (EPI) and cisplatin as first-line line chemotherapy for advanced ovarian carcinoma. A phase I study was carried out to evaluate the d
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::319839614861130ccfcc934bcc61c4ed
https://doi.org/10.1097/00001813-200306000-00006
Zobrazit plný text záznamu
6
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype
Autor: Nello Grassi, G. Dardanoni, Carla Tubiolo, Antonio Russo, Ida Albanese, Nicolo' Gebbia, Manuela Migliavacca, Viviana Bazan, Sergio Salerno, Mario Adelfio Latteri, R. Labianca, Ines Zanna, M. La Farina, Rosa Maria Tomasino
Publikováno v: Annals of Oncology. 13:1438-1446
Background: K-ras mutations, one of the earliest events observed in colorectal carcinogenesis, are mostly found in codons 12 and 13, and less frequently in codon 61, all three of which are estimated to be critical for the biological activity of the p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f80ac5f8ba5ca44c9b63b6a26ee86d64
https://doi.org/10.1093/annonc/mdf226
Zobrazit plný text záznamu
7
Ras family genes: An interesting link between cell cycle and cancer
Autor: Nicolo' Gebbia, Viviana Bazan, Antonio Russo, Marcella Macaluso, Caterina Cinti, Giuseppe Russo
Publikováno v: Journal of cellular physiology
192 (2002): 125–130.
info:cnr-pdr/source/autori:Macaluso M., Russo G., Cinti C., Barzan V., Gebbia N., Russo A./titolo:Ras family genes: an interesting link between cell cycle and cancer/doi:/rivista:Journal of cellular physiology (Print)/anno:2002/pagina_da:125/pagina_a:130/intervallo_pagine:125–130/volume:192
Ras genes are evolutionary conserved and codify for a monomeric G protein binding GTP (active form) or GDP (inactive form). The ras genes are ubiquitously expressed although mRNA analysis suggests different level expression in tissue. Mutations in ea
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f588915fc42c794e440f99af35087e98
https://doi.org/10.1002/jcp.10109
Zobrazit plný text záznamu
8
5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: A multicenter randomised phase II study of the Southern Italy Oncology Group
Autor: G. Paoletti, Nicolo' Gebbia, T. Pedicini, Vittorio Gebbia, Francesco Giuliani, Evaristo Maiello, M. Lopez, Nicolò Borsellino, S. Fortunato, S. Cigolari, Giuseppe Colucci
Publikováno v: Annals of Oncology. 11:1045-1052
The combination regimen CPT-11 plus bolus and infusion 5-fluorouracil (5-FU) with high-dose leucovorin (hybrid regimen LV5FU2) has been tested for activity and toxicity against advanced colorectal carcinoma in a randomised, multicenter phase II trial
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dfff2756a753177ca92399fd3023d65
https://doi.org/10.1023/a:1008342928408
Zobrazit plný text záznamu
9
Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM)
Autor: S. Cariello, F. Riccardi, Giuseppe Colucci, Nicolo' Gebbia, Domenico Galetta, Vittorio Gebbia
Publikováno v: British Journal of Cancer
A multicentric, prospective phase III study was carried out with the aim of testing the so-called 'worst drug rule' hypothesis, which suggests the use of an effective but 'less active' regimen that first eradicates tumoral cells resistant to a second
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b3bbc5b604dc18b914d4428c6200a0b
https://doi.org/10.1038/bjc.1997.586
Zobrazit plný text záznamu
10
Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck
Autor: Antonio Farris, Vittorio Gebbia, Emilio Bajetta, Carlo Di Gregorio, Francesco Moschella, Luigi Curreli, Biagio Agostara, Glovanni Mantovani, Alberto Desogus, Nicolo' Gebbia
Publikováno v: Cancer. 79:1394-1400
BACKGROUND The combination of vinorelbine (VNR), cisplatin (CDDP), and 5-fluorouracil (5-FU) has previously been shown to be active in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCHNC). This multicenter Phase II study w
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56630aa3b680ce0ef2d4dfa386d18bb4
https://doi.org/10.1002/(sici)1097-0142(19970401)79:7<1394::aid-cncr17>3.0.co
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje